Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
Amelia D. Dahlén, Giovanna Dashi, Ivan Maslov, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 169

Showing 1-25 of 169 citing articles:

Flavonoids as dual-target inhibitors against α-glucosidase and α-amylase: a systematic review of in vitro studies
Thua-Phong Lam, Ngoc-Vi Nguyen Tran, Long-Hung Dinh Pham, et al.
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 31
The Effect of HBV Therapy on Glycemic Control in HBV‐Infected Patients With Diabetes: A 90‐day Multicenter Study
Qi Liu, Jie Huang, Jingyi Hu, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access | Times Cited: 1
Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations
Isabella Hetherington, Hana Totary-Jain
Molecular Therapy (2022) Vol. 30, Iss. 10, pp. 3106-3117
Open Access | Times Cited: 52
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
Stefania Chiappini, Rachel Vickers‐Smith, Daniel R. Harris, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 994-994
Open Access | Times Cited: 32
An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus
Mohamed Mahgoub, Ifrah Ismail Ali, Jennifer Adeghate, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9328-9328
Open Access | Times Cited: 22
Novel thiazolidin-4-one benzenesulfonamide hybrids as PPARγ agonists: Design, synthesis and in vivo anti-diabetic evaluation
Islam H. Ali, Rasha M. Hassan, Ahmed M. El Kerdawy, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116279-116279
Closed Access | Times Cited: 13
Assessment of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer’s disease: A population-based study
Mar Garcia-Zamora, Gemma García‐Lluch, Lucrecia Moreno, et al.
Pharmacological Research (2024) Vol. 206, pp. 107295-107295
Open Access | Times Cited: 8
Synthesis, in vitro potency of inhibition, enzyme kinetics and in silico studies of quinoline-based α-glucosidase inhibitors
Minoo Khalili Ghomi, Navid Dastyafteh, Mohammad Nazari Montazer, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Recent advances and structure-activity relationship studies of DPP-4 inhibitors as anti-diabetic agents
Shipra Singhal, Vaishali M. Patil, Saroj Verma, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107277-107277
Closed Access | Times Cited: 7
The Sensory Mechanisms of Nutrient-Induced GLP-1 Secretion
Anna Pii Hjørne, Ida M. Modvig, Jens J. Holst
Metabolites (2022) Vol. 12, Iss. 5, pp. 420-420
Open Access | Times Cited: 32
GLP-1R Signaling and Functional Molecules in Incretin Therapy
Wenwei Wan, Qikai Qin, Linshan Xie, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 751-751
Open Access | Times Cited: 19
Natural products from plants targeting key enzymes for the future development of antidiabetic agents
Rachel Mata, Laura Flores‐Bocanegra, Berenice Ovalle‐Magallanes, et al.
Natural Product Reports (2023) Vol. 40, Iss. 7, pp. 1198-1249
Closed Access | Times Cited: 19
Arylureidoaurones: Synthesis, in vitro α-glucosidase, and α-amylase inhibition activity
Mohammad Kazempour-Dizaji, Somayeh Mojtabavi, Arash Sadri, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106709-106709
Closed Access | Times Cited: 17
Anti-obesity and anti-diabetic bioactive peptides: A comprehensive review of their sources, properties, and techno-functional challenges
Tolulope Joshua Ashaolu, Opeyemi Joshua Olatunji, Aslı Can Karaça, et al.
Food Research International (2024) Vol. 187, pp. 114427-114427
Closed Access | Times Cited: 6
In vitro and in silico studies reveal antidiabetic properties of arylbenzofurans from the root bark of Morus mesozygia Stapf
Katherine O. Olufolabo, Kai Lüersen, Samuel A. Oguntimehin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Predicting therapeutic and side effects from drug binding affinities to human proteome structures
Ryusuke Sawada, Yuko Sakajiri, Tomokazu Shibata, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 110032-110032
Open Access | Times Cited: 5
VIRTUAL SCREENING OF THE ZIMBABWE NATURAL PRODUCT DATABASE FOR GLUCOKINASE ACTIVATORS
EZEKIEL MAKAMBWA, Masteria Yunovilsa Putra, ADHA DHASTU ILLAHI, et al.
Asian Journal of Pharmaceutical and Clinical Research (2025), pp. 56-67
Open Access
In Silico and In Vivo Evaluation of Novel 2-Aminobenzothiazole Derivative Compounds as Antidiabetic Agents
J. A. SALAZAR, Miguel Ángel Serra Valdés, Alejandro Canales Cruz, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 909-909
Open Access
Diabetes Mellitus: The Pathophysiology as a Canvas for Management Elucidation and Strategies
Franklyn Nonso Iheagwam, Olawumi Toyin Iheagwam
Medicine in Novel Technology and Devices (2025), pp. 100351-100351
Open Access
The Many Facets of PPAR-γ Agonism in Obesity and Associated Comorbidities: Benefits, Risks, Challenges, and Future Directions
Dimitris Kounatidis, Natalia G. Vallianou, Eleni Rebelos, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Closed Access
Advances of deep Neural Networks (DNNs) in the development of peptide drugs
Yuzhen Niu, Pingyang Qin, Ping Lin
Future Medicinal Chemistry (2025), pp. 1-15
Closed Access
Novel carbazole-thiadiazole derivatives as α-amylase and α-glucosidase inhibitors: Design, biological evaluation, and computational insights
İrfan Çapan, Mohammed Hawash, Mohammed T. Qaoud, et al.
Bioorganic Chemistry (2025), pp. 108243-108243
Closed Access
Lepidine potentiates the antidiabetic effect of metformin in nicotinamide/streptozotocin-induced diabetic male rats
Ayman S. Soliman, A. A. Abdel-Fattah, Osama M. Ahmed, et al.
Archives of Physiology and Biochemistry (2025), pp. 1-13
Closed Access
Therapeutic Potential and Challenges of Pioglitazone in Cancer Treatment
Maria Vasileiou, Sotirios Charalampos Diamantoudis, Christina Tsianava, et al.
Applied Sciences (2025) Vol. 15, Iss. 4, pp. 1925-1925
Open Access
Effects of Anti-Diabetic Drugs on Erectile Dysfunction: A Systematic Review and Meta-Analysis
Bo Yang, Hui-Yun Cheng, Yu‐Feng Hu, et al.
Diabetes Metabolic Syndrome and Obesity (2025) Vol. Volume 18, pp. 467-478
Open Access
Page 1 - Next Page

Scroll to top